dactinomycin has been researched along with Neuroectodermal Tumors, Primitive in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (10.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 6 (60.00) | 29.6817 |
2010's | 1 (10.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Gao, L; Huang, G; Ji, Y; Li, K; Ou, Y; Xie, W | 1 |
Brabetz, S; Chan, JA; Herold-Mende, C; Kool, M; Korshunov, A; Mack, N; Milde, T; Pfister, SM; Schmidt, C; Schubert, NA; Schwalm, B; Selt, F; Witt, O | 1 |
Iwasaki, Y; Kobayashi, H; Kubota, K; Terasaka, S; Yamaguchi, S | 1 |
Billups, C; Cheshire, PJ; Fouladi, M; Friedman, HS; Houghton, PJ; Leggas, M; Peterson, JK; Stewart, CF; Woo, MH | 1 |
Dickman, PS; Donaldson, SS; Fryer, CJ; Gebhardt, MC; Grier, HE; Krailo, MD; Link, MP; Meyers, PA; Miser, JS; Moore, S; Perlman, EJ; Pritchard, DJ; Rausen, AR; Tarbell, NJ; Vietti, TJ | 2 |
Donner, LR; Teshima, I | 1 |
DUKAT, EG; KJELLBERG, RN; MARK, VH; SOLOWAY, AH | 1 |
Askin, FB; Bhatia, S; Burden, L; Chen, Z; Dickman, PS; Grier, HE; Krailo, MD; Link, MP; Meyers, PA; Miser, JS; Perlman, EJ; Rausen, AR; Robison, LL; Vietti, TJ | 1 |
Chi, JG; Cho, SS; Choi, EY; Chung, DH; Hwang, DH; Jang, JJ; Jun, BH; Kim, SH; Lee, IS; Park, SH; Sohn, HW; Sung, UA | 1 |
1 review(s) available for dactinomycin and Neuroectodermal Tumors, Primitive
Article | Year |
---|---|
Primitive neuroectodermal tumor of urinary bladder: A case report and literature review.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child; Combined Modality Therapy; Cyclophosphamide; Cystectomy; Dactinomycin; Female; Humans; Laparoscopy; Lymph Node Excision; Male; Middle Aged; Neuroectodermal Tumors, Primitive; Treatment Outcome; Urinary Bladder Neoplasms; Vincristine | 2020 |
3 trial(s) available for dactinomycin and Neuroectodermal Tumors, Primitive
Article | Year |
---|---|
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Disease Progression; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Male; Neuroectodermal Tumors, Primitive; Prognosis; Sarcoma; Sarcoma, Ewing; Survival Rate; Treatment Failure; Vincristine | 2003 |
Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Ifosfamide; Neoplasm Metastasis; Neuroectodermal Tumors, Primitive; Sarcoma, Ewing; Survival Analysis; Treatment Outcome; Vincristine | 2004 |
Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Incidence; Infant; Leukemia, Myeloid; Male; Neoplasms, Second Primary; Neural Tube Defects; Neuroectodermal Tumors, Primitive; Proportional Hazards Models; Risk; Sarcoma, Ewing; Vincristine | 2007 |
6 other study(ies) available for dactinomycin and Neuroectodermal Tumors, Primitive
Article | Year |
---|---|
Preclinical drug screen reveals topotecan, actinomycin D, and volasertib as potential new therapeutic candidates for ETMR brain tumor patients.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Brain Neoplasms; Cell Cycle; Cell Proliferation; Child, Preschool; Dactinomycin; Female; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors, Primitive; Pteridines; Topoisomerase I Inhibitors; Topotecan; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2017 |
Primary Ewing's sarcoma: peripheral primitive neuroectodermal tumour of the jugular foramen.
Topics: 12E7 Antigen; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Cell Adhesion Molecules; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Diagnosis, Differential; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Neuroectodermal Tumors, Primitive; Phosphopyruvate Hydratase; Sarcoma, Ewing; Skull Base Neoplasms; Synaptophysin; Tomography, X-Ray Computed; Vincristine | 2008 |
Relation between Irofulven (MGI-114) systemic exposure and tumor response in human solid tumor xenografts.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Chromatography, High Pressure Liquid; Cyclophosphamide; Dacarbazine; Dactinomycin; Disease-Free Survival; Doxorubicin; Female; Glioblastoma; Glioma; Humans; Medulloblastoma; Mice; Mice, Inbred CBA; Mice, Inbred ICR; Mice, SCID; Neoplasms; Neuroblastoma; Neuroectodermal Tumors, Primitive; Radiation Chimera; Random Allocation; Rhabdoid Tumor; Rhabdomyosarcoma, Embryonal; Sesquiterpenes; Tumor Cells, Cultured; Vincristine; Xenograft Model Antitumor Assays | 2002 |
Peripheral medulloepithelioma: an immunohistochemical, ultrastructural, and cytogenetic study of a rare, chemotherapy-sensitive, pediatric tumor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Child; Chromosomes, Human, Pair 2; Chromosomes, Human, Pair 8; Cyclophosphamide; Dactinomycin; Desmosomes; Disease-Free Survival; Doxorubicin; Female; Humans; Ifosfamide; Immunohistochemistry; Neoplasm Proteins; Neuroectodermal Tumors, Primitive; Pelvic Neoplasms; Remission Induction; Spectral Karyotyping; Treatment Outcome; Trisomy; Vincristine | 2003 |
CHEMOTHERAPY OF BRAIN TUMORS. I. TRANSPLANTED MURINE EPENDYMOBLASTOMAS.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Brain Neoplasms; Cyclophosphamide; Dactinomycin; Ependymoma; Mannitol; Melphalan; Mice; Neoplasms; Neoplasms, Experimental; Neuroectodermal Tumors, Primitive; Pharmacology; Research; Toxicology | 1964 |
Engagement of CD99 induces apoptosis through a calcineurin-independent pathway in Ewing's sarcoma cells.
Topics: 12E7 Antigen; Antibodies, Monoclonal; Antigens, CD; Apoptosis; Calcineurin; Calcium; Caspase Inhibitors; Caspases; Cell Adhesion Molecules; Cell Differentiation; Cyclosporine; Dactinomycin; Fluorescent Antibody Technique, Indirect; Humans; Membrane Potentials; Microscopy, Confocal; Microscopy, Electron; Neuroblastoma; Neuroectodermal Tumors, Primitive; Sarcoma, Ewing; Tacrolimus; Tumor Cells, Cultured | 1998 |